Previous Article | Next Article 
Journal of Virology, July 2005, p. 8079-8089, Vol. 79, No. 13
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.13.8079-8089.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Hepatitis C Virus E2-CD81 Interaction Induces Hypermutation of the Immunoglobulin Gene in B Cells
Keigo Machida,1
Kevin T.-H. Cheng,1
Nicole Pavio,1
Vicky M.-H. Sung,1 and
Michael M. C. Lai1,2*
Department of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, 2011 Zonal Ave., Los Angeles, California 90033,1
Institute of Molecular Biology, Academia Sinica, Nankang, Taipei, Taiwan2
Received 26 November 2004/
Accepted 7 March 2005
Hepatitis C virus (HCV) is one of the leading causes of chronic liver diseases and B-lymphocyte proliferative disorders, including mixed cryoglobulinemia and B-cell lymphoma. It has been suggested that HCV infects human cells through the interaction of its envelope glycoprotein E2 with a tetraspanin molecule CD81, the putative viral receptor. Here, we show that the engagement of B cells by purified E2 induced double-strand DNA breaks specifically in the variable region of immunoglobulin (VH) gene locus, leading to hypermutation in the VH genes of B cells. Other gene loci were not affected. Preincubation with the anti-CD81 monoclonal antibody blocked this effect. E2-CD81 interaction on B cells triggered the enhanced expression of activation-induced cytidine deaminase (AID) and also stimulated the production of tumor necrosis factor alpha. Knockdown of AID by the specific small interfering RNA blocked the E2-induced double-strand DNA breaks and hypermutation of the VH gene. These findings suggest that HCV infection, through E2-CD81 interaction, may modulate host's innate or adaptive immune response by activation of AID and hypermutation of immunoglobulin gene in B cells, leading to HCV-associated B-cell lymphoproliferative diseases.
* Corresponding author. Mailing address: Department of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, 2011 Zonal Ave., Los Angeles, CA 90033. Phone: (323) 442-1748. Fax: (323) 442-1721. E-mail:
michlai{at}usc.edu.
Supplemental material for this article may be found at http://jvi.asm.org/.
Journal of Virology, July 2005, p. 8079-8089, Vol. 79, No. 13
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.13.8079-8089.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Machida, K., Liu, J.-C., McNamara, G., Levine, A., Duan, L., Lai, M. M. C.
(2009). Hepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb Pathway. J. Virol.
83: 12590-12600
[Abstract]
[Full Text]
-
Burlone, M. E., Budkowska, A.
(2009). Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J. Gen. Virol.
90: 1055-1070
[Abstract]
[Full Text]
-
Machida, K., Kondo, Y., Huang, J. Y., Chen, Y.-C., Cheng, K. T.-H., Keck, Z., Foung, S., Dubuisson, J., Sung, V. M.-H., Lai, M. M. C.
(2008). Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein. J. Virol.
82: 6711-6720
[Abstract]
[Full Text]
-
Viswanatha, D S, Dogan, A
(2007). Hepatitis C virus and lymphoma. J. Clin. Pathol.
60: 1378-1383
[Abstract]
[Full Text]
-
Perez-Duran, P., de Yebenes, V. G., Ramiro, A. R.
(2007). Oncogenic events triggered by AID, the adverse effect of antibody diversification. Carcinogenesis
28: 2427-2433
[Abstract]
[Full Text]
-
Giordano, T. P., Henderson, L., Landgren, O., Chiao, E. Y., Kramer, J. R., El-Serag, H., Engels, E. A.
(2007). Risk of Non-Hodgkin Lymphoma and Lymphoproliferative Precursor Diseases in US Veterans With Hepatitis C Virus. JAMA
297: 2010-2017
[Abstract]
[Full Text]
-
Owsianka, A. M., Timms, J. M., Tarr, A. W., Brown, R. J. P., Hickling, T. P., Szwejk, A., Bienkowska-Szewczyk, K., Thomson, B. J., Patel, A. H., Ball, J. K.
(2006). Identification of conserved residues in the e2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.. J. Virol.
80: 8695-8704
[Abstract]
[Full Text]
-
Suarez, F., Lortholary, O., Hermine, O., Lecuit, M.
(2006). Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood
107: 3034-3044
[Abstract]
[Full Text]
-
Machida, K., Cheng, K. T. H., Sung, V. M.-H., Levine, A. M., Foung, S., Lai, M. M. C.
(2006). Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6. J. Virol.
80: 866-874
[Abstract]
[Full Text]
-
Rosa, D., Saletti, G., De Gregorio, E., Zorat, F., Comar, C., D'Oro, U., Nuti, S., Houghton, M., Barnaba, V., Pozzato, G., Abrignani, S.
(2005). Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. USA
102: 18544-18549
[Abstract]
[Full Text]